Deal or No deal17 Dec 2020 11:23
I tend to agree Bigeasy. The bid risk for any suitor and Sareum is the outcome of any clinical trials, with 1801 in particular. I believe that this is the sticking point on any agreement. Obviously if any interested party waits for the results of a successful trial, then the cost doubles, at least, and there will be many more interested parties , if the trials are not successful, then Sareum are in a weaker position. The grant has really helped us in any negotiation we happen to be in.
I would say a deal at this stage, prior to any trials, would cost the buyer £650m and if they wait for successful then all bets are off. Lets wait for the call from the banker. GLA.